The Canada Medical Elastomer Market was valued at $163.1 Million in 2024 and projected to reach to $224.2 Million by 2029, representing a compound annual growth rate of 6.6%. Canada's medical elastomer market is poised for sustained growth driven by the country's aging demographic profile and expanding healthcare expenditures.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada's medical elastomer market is valued at USD 163.1 million in 2024, with a projected CAGR of 6.6% through 2029, reaching USD 224.2 million by forecast end.
Canada's advanced healthcare system and universal coverage drive consistent demand for high-quality medical devices incorporating elastomeric materials across hospitals and clinics.
As a key North American market, Canada benefits from proximity to the US market and cross-border medical device manufacturing, enhancing supply chain efficiency and innovation transfer.
Increasing adoption of minimally invasive surgical devices, aging population demographics, and rising healthcare spending support steady expansion of medical elastomer applications in Canada.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | -GASKETS (Application) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 8.3% from 2024 to 2029 |
| Largest Segment | THERMOSET ELASTOMERS (Type) |
| Market Size Base Year (Billions) | ~USD 9.58 (2024) |
| Revenue Forecast (Billions) | ~USD 14.27 (2029) |
| Segments Covered | End-Use Industry, Application, Type |
3 segment dimensions are covered across the global market.
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CATHETERS | 115.3 | 124.3 | 133.9 | 144 | 154.9 | 166.5 | 7.6 | ||||||||||||||
| GLOVES | 85.5 | 91.8 | 98.5 | 105.6 | 113.1 | 121.1 | 7.2 | ||||||||||||||
| IMPLANTS | 50 | 54.5 | 59.3 | 64.4 | 70 | 76.1 | 8.7 | ||||||||||||||
| MEDICAL & INFUSION BAGS | 61.1 | 65.9 | 71 | 76.5 | 82.3 | 88.5 | 7.7 | ||||||||||||||
| MEDICAL TUBING | 146.6 | 159.1 | 172.6 | 187 | 202.6 | 219.3 | 8.4 | ||||||||||||||
| OTHER APPLICATIONS | 70.1 | 75.5 | 81.2 | 87.3 | 93.7 | 100.7 | 7.5 | ||||||||||||||
| SYRINGES | 76.2 | 82.6 | 89.4 | 96.8 | 104.7 | 113.2 | 8.2 | ||||||||||||||
| –DOUBLE CHAMBER | 22.4 | 24.3 | 26.2 | 28.4 | 30.6 | 33.1 | 8.1 | ||||||||||||||
| –GASKETS | 4.3 | 4.8 | 5.2 | 5.8 | 6.3 | 6.9 | 9.9 | 3.3 | 3.6 | 4 | 4.4 | 4.9 | 5.4 | 10.4 | 14 | 15.3 | 16.6 | 18.1 | 19.7 | 21.5 | 8.9 |
| –NON-PREFILLED SYRINGES | 15.4 | 16.7 | 18.2 | 19.7 | 21.4 | 23.2 | 8.6 | ||||||||||||||
| –PRE-FILLED SYRINGES | 20.1 | 21.8 | 23.7 | 25.7 | 27.8 | 30.2 | 8.4 | ||||||||||||||
| –RUBBER STOPPERS | 15.8 | 17.1 | 18.5 | 19.9 | 21.5 | 23.2 | 8 | 12.1 | 13.1 | 14.2 | 15.3 | 16.5 | 17.8 | 8.1 | 26.7 | 28.7 | 30.9 | 33.2 | 35.7 | 38.3 | 7.5 |
| –SINGLE CHAMBER | 38.7 | 41.6 | 44.8 | 48.1 | 51.7 | 55.5 | 7.5 | ||||||||||||||
| –VIALS | 40.7 | 44 | 47.6 | 51.4 | 55.4 | 59.8 | 8 | ||||||||||||||
| TOTAL | 604.8 | 653.6 | 705.8 | 761.6 | 821.2 | 885.4 | 7.9 |
Canada's medical elastomer market was valued at USD 163.1 million in 2024 and is expected to grow to USD 224.2 million by 2029.
Canada's medical elastomer market is projected to grow at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2029.
In Canada, medical elastomers are primarily used in seals, gaskets, tubing, catheters, and biocompatible components for medical devices and pharmaceutical applications.
Canada's medical elastomer products must comply with Health Canada regulations, ISO standards, and biocompatibility requirements to ensure patient safety and device efficacy.
Key growth drivers in Canada include an aging population, increased healthcare spending, rising demand for advanced medical devices, and stringent quality standards that favor premium elastomeric materials.
The study involved four major activities in estimating the market size of the medical elastomer market. Exhaustive secondary research was done to collect information on the market, the peer market, and the grandparent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources have been referred to for identifying and collecting information for this study. These secondary sources include annual reports, press releases, investor presentations of companies, white papers, certified publications, trade directories, articles from recognized authors, gold standard and silver standard websites, and databases. Secondary research has been used to obtain key information about the value chain of the industry, monetary chain of the market, the total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.
The medical elastomer market comprises several stakeholders in the value chain, which include manufacturers, and end users. Various primary sources from the supply and demand sides of the medical elastomer market have been interviewed to obtain qualitative and quantitative information. The primary interviewees from the demand side include key opinion leaders in industrial sectors. The primary sources from the supply side include manufacturers, associations, and institutions involved in the medical elastomer industry. Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to type, material, end-use industry, and region. Stakeholders from the demand side, such as CIOs, CTOs, and CSOs were interviewed to understand the buyer’s perspective on the suppliers, products, component providers, and their current usage of medical elastomer and outlook of their business, which will affect the overall market.
The breakdown of profiles of the primary interviewees is illustrated in the figure below:
Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022 available in the public domain, product portfolios, and geographical presence.
Other designations include consultants and sales, marketing, and procurement managers.
To know about the assumptions considered for the study, download the pdf brochure
The top-down and bottom-up approaches have been used to estimate and validate the size of the medical elastomer market.

After arriving at the total market size from the estimation process, the overall market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and sub-segments, the data triangulation and market breakdown procedures have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market size has been validated by using both the top-down and bottom-up approaches and primary interviews. Hence, for every data segment, there have been three sources—top-down approach, bottom-up approach, and expert interviews. The data was assumed correct when the values arrived from the three sources matched.
Elastomers are advanced polymers which possess both elastic and viscous properties. Due to the features of these materials, which include biocompatibility and flexibility and durability, they are widely used in the medical field. They are often found in a range of medical devices and applications, including, syringes, tubes, implants, and drug delivery devices. Medical elastomers may be placed in two categories: thermoplastic elastomers (TPEs) and thermoset elastomers. TPEs are considered highly important in fabricating complex parts of medical devices due to their flexibility which reduces the operation cost for production.
Full forecast, segment splits, and company analysis for all Medical Elastomer Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report